GlassScriptPhysician profile
Jordan S Moseson
NPI 1790060754
$3,580.49
in general payments reported to CMS, 2019-2025
12 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $13.33 · 2021: $180 · 2022: $1,376 · 2024: $1,763 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $951 · Food and Beverage: $845 · Education: $58.70 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $951.40 |
| Food and Beverage | $845.04 |
| Education | $58.70 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,027.01 | 2019-2025 | |
| Medtronic, INC. | $999.82 | 2022 | |
| Axonics, INC. | $227.22 | 2024 | Axonics |
| Baxter Healthcare | $125.00 | 2021 | |
| Covidien LP | $40.00 | 2019 | |
| Astellas Pharma US INC | $33.06 | 2025 | Veozah |
| Braintree Laboratories, INC. | $31.21 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $26.33 | 2021-2022 | |
| Innovation Technologies INC | $23.15 | 2021 | |
| Amarin Pharma, INC. | $17.89 | 2019 | |
| Lilly USA, LLC | $16.05 | 2024 | Zepbound, Mounjaro |
| Novo Nordisk INC | $13.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Moseson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.